Soothing and Re-epithelizing Activity of New Cosmetic Formulations in Comparison to Placebo and Untreated Control Area

Sensitive Skin Clinical Trial

Official title:
Soothing and Re-epithelizing Activity of New Cosmetic Formulations in Comparison to Placebo and Untreated Control Area

Status Completed

Clinical Trial Summary

Open clinical study to evaluate the soothing and re-epithelizing activity of a single application of two cometic formulations ("P926 - LICHTENA DermAD CREMA VISO" and "P927 - LICHTENA DermAD CREMA CORPO") on experimentally induced erythema by repeated tape stripping on the forearm (volar surface) of 20 healthy volunteers.

Study products activity was assessed in comparison to placebo ("P926P - LICHTENA DermAD CREMA VISO - PLACEBO") and versus untreated control area.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Sensitive Skin

Clinical Trial Details

NCT number	NCT03464890
Study type	Interventional
Source	Derming SRL
Contact
Status	Completed
Phase	N/A
Start date	January 22, 2018
Completion date	February 13, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05094700` - A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin Participants	N/A
Enrolling by invitation	`NCT01871883` - TRPV Expression in Subjects With Sensitive Skin	Phase 4
Active, not recruiting	`NCT04898582` - Clinical Benefit of M89PB in Subjects With Rosacea Associated With Erythema and Sensitive Skin	N/A
Completed	`NCT03279003` - Study of the Efficacy and Tolerance of Light Therapy in Sensitive Skin	N/A
Completed	`NCT05630027` - A Scalp Lotion Toimprove Sensitive Scalp Syndrome
Completed	`NCT03958968` - Impact of Exposure to Cosmetics on Sensitive Skin
Completed	`NCT03081403` - Quantitative Sensory Testing in Subjects With Sensitive Skin or Not	N/A